Malaysia
Search
Sign In
Change Password
Points
Sign Out
Top Medical News
There is a nonlinear association between body mass index (BMI) and risk of lung cancer mortality, where individuals with higher BMI have less risk of death, according to a recent meta-analysis.
Statins may have therapeutic potential in chronic obstructive pulmonary disease (COPD), improving exercise tolerance, lung function and health-related quality of life, especially in patients with comorbid cardiovascular disease, elevated systemic inflammation or hyperlipidaemia, according to a recent study.
A large database analysis confirms a high incidence of undetected sleep-disordered breathing in obese hospitalized patients in selected medical services. In addition, adherence to therapy and early intervention shows a survival benefit.
Switching from bilevel positive airway pressure (BiPAP) to continuous positive airway pressure (CPAP) ventilation therapy may be safe and cost-effective in patients with obesity hypoventilation syndrome and sleep apnoea, a small study presented at the ERS 2017 has shown.
Initiating therapy with fluticasone furoate plus vilanterol resulted in improved asthma control over usual care in individuals with symptomatic asthma, according to results of the Salford Lung Study presented at ERS 2017.
Hormone replacement therapy (HRT) may help delay lung function decline in middle-aged women, according to results of a longitudinal analysis presented at ERS Congress 2017, demonstrating a possible role for female sex hormones in the preservation of lung function.
Cessation of continuous positive airway pressure (CPAP) elicits the occurrence of obstructive sleep apnoea (OSA) associated with sympathetic and adrenocortical activation thereby increasing plasma free fatty acids (FFAs) and glucose during sleep, a recent study has found. Repeated exposure to these metabolic changes may lead to diabetes and cardiovascular disease.
Special Reports
Persons with underlying medical conditions are at higher risk of influenza-associated hospitalization.
Tiotropium/olodaterol (Spiolto® Respimat®, Boehringer Inghelheim) is the latest dual bronchodilator therapy available in Malaysia for COPD.
Chronic obstructive pulmonary disease (COPD) is the fourth cause of global mortality, with experts predicting a potential future rise in the prevalence rates of COPD.
Allergic rhinitis (AR) is a common global health problem that poses a significant impact on the quality of life and productivity of affected patients. At the Ear, Nose and Throat (ENT) Summit 2017 held recently at Hilton Sentral, Kuala Lumpur, Malaysia, Associate Professor Marysia P Tiongco-Recto was invited by A. Menarini to deliver a lecture on the potential of modern second-generation antihistamines, particularly bilastine (Bilaxten®) in the management of AR.
With the dramatic evolution of sequencing technology and emergence of effective targeted therapies, using a comprehensive molecular approach to guide treatment decisions is becoming more accessible and applicable in the clinic. At the recent Foundation Medicine meeting in Hong Kong, Dr Alexander Drilon, clinical director of the Early Drug Development Service at Memorial Sloan Kettering Cancer Center (MSKCC), New York, US, discussed the current landscape and potential benefits of comprehensive molecular profiling in non-small cell lung cancer (NSCLC).
The common cold is one of the most widespread illness and is a leading cause of visits to the doctor and absenteeism from school and work. While many may see it as merely a harmless inconvenience, the significant repercussions it brings, especially among children cannot be denied. MIMS JPOG recently spoke to Associate Professor Datin Dr Asmiati Abd Hamid to gain her perspectives on the role of zinc and vitamin C in treating paediatric common cold to reduce morbidity and economic losses attributed to the condition.
As targeted cancer therapy options are increasing, it is becoming more important to choose the most appropriate treatment for patients with cancer. At a Roche-sponsored symposium held during the 2nd ESMO Asia Congress in Singapore, four experts discussed the potential of comprehensive genomic profiling (CGP) for personalizing cancer care and helping healthcare professionals to make the best treatment decisions for individual patients.
Conference Reports
Switching from bilevel positive airway pressure (BiPAP) to continuous positive airway pressure (CPAP) ventilation therapy may be safe and cost-effective in patients with obesity hypoventilation syndrome and sleep apnoea, a small study presented at the ERS 2017 has shown.
Initiating therapy with fluticasone furoate plus vilanterol resulted in improved asthma control over usual care in individuals with symptomatic asthma, according to results of the Salford Lung Study presented at ERS 2017.
Hormone replacement therapy (HRT) may help delay lung function decline in middle-aged women, according to results of a longitudinal analysis presented at ERS Congress 2017, demonstrating a possible role for female sex hormones in the preservation of lung function.
Doctors need to understand the relationship between climate change and health in order to better communicate the risks with patients and influence public policy, says a respiratory physician.
Once-daily dosing with Relvar® delivered via an easy-to-use Ellipta® device provides better symptom control and reduces disease exacerbations in asthma.
Persons with underlying medical conditions are at higher risk of influenza-associated hospitalization.
Once-daily dosing with Relvar® Ellipta® provides better symptom control and reduced disease exacerbations in asthma.
